SPCC13B11.04c Antibody

What is SPCC13B11.04c and what is known about its function?

SPCC13B11.04c is a protein in Schizosaccharomyces pombe (fission yeast) with UniProt accession number O74540 . While its precise function remains under investigation, research suggests potential involvement in transcriptional regulation pathways, particularly in relation to zinc homeostasis mechanisms. Some studies indicate it may be connected to the Loz1 transcription factor regulatory network, which plays a role in zinc-responsive gene expression . Current research efforts are focused on further characterizing its biochemical properties and cellular functions through various molecular approaches. Understanding SPCC13B11.04c is part of broader efforts to map the functional genome of S. pombe, which serves as an important model organism for eukaryotic cell biology.

What are the optimal storage and handling conditions for SPCC13B11.04c antibody?

SPCC13B11.04c antibody should be stored at -20°C or -80°C immediately upon receipt to maintain its activity and specificity . Repeated freeze-thaw cycles should be strictly avoided as they can significantly compromise antibody performance through protein denaturation and aggregation. The antibody is typically supplied in a liquid formulation containing 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative . When working with the antibody, aliquoting into single-use volumes is strongly recommended to minimize freeze-thaw cycles. For short-term use during experiments, store antibody aliquots on ice and return to -20°C promptly after use. Always centrifuge the antibody vial briefly before opening to collect the liquid at the bottom of the tube and ensure accurate pipetting.

What validated applications exist for SPCC13B11.04c antibody?

The SPCC13B11.04c antibody has been specifically validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . In Western blotting, this antibody enables detection of the native SPCC13B11.04c protein and recombinant forms expressed in S. pombe. ELISA applications may include both direct and sandwich ELISA formats for quantitative measurement of the target protein. The antibody's specificity for Schizosaccharomyces pombe (strain 972 / ATCC 24843) makes it particularly valuable for fission yeast research . When designing experiments, researchers should consider that this polyclonal antibody has been affinity-purified using the recombinant SPCC13B11.04c protein as the immunogen, which enhances its specificity for the target.

How can researchers verify antibody specificity for SPCC13B11.04c?

Verifying antibody specificity is a critical step before conducting extensive experiments with SPCC13B11.04c antibody. Begin with Western blot analysis using wild-type S. pombe lysates alongside a negative control from a SPCC13B11.04c deletion strain to confirm the absence of signal in the knockout. Including a positive control with recombinant SPCC13B11.04c protein provides further validation of antibody specificity. Immunoprecipitation followed by mass spectrometry can conclusively identify proteins recognized by the antibody and potential cross-reactive species. Additionally, researchers should perform peptide competition assays by pre-incubating the antibody with excess recombinant SPCC13B11.04c protein before immunostaining or Western blotting; a significant reduction in signal indicates specific binding. These validation steps are particularly important for polyclonal antibodies like anti-SPCC13B11.04c, which contain multiple antibody clones recognizing different epitopes.

What are the optimal Western blot protocols for SPCC13B11.04c detection?

For optimal Western blot detection of SPCC13B11.04c, begin with thorough sample preparation by lysing S. pombe cells in a buffer containing protease inhibitors to prevent degradation of the target protein. Effective cell lysis can be achieved using glass bead disruption in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail. Separate 20-40 μg of total protein per lane on a 10-12% SDS-PAGE gel, followed by transfer to a PVDF membrane using standard protocols. Block the membrane with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature, then incubate with SPCC13B11.04c antibody at a 1:1000 dilution in blocking buffer overnight at 4°C . After washing with TBST, incubate with an appropriate HRP-conjugated secondary anti-rabbit antibody (1:5000 dilution) for 1 hour at room temperature, followed by standard chemiluminescent detection. Always include positive and negative controls to validate the specificity of the observed bands.

How should chromatin immunoprecipitation (ChIP) experiments be designed for SPCC13B11.04c?

Chromatin immunoprecipitation using SPCC13B11.04c antibody requires careful optimization to obtain meaningful results about potential DNA associations. Begin by crosslinking S. pombe cells with 1% formaldehyde for 15 minutes at room temperature, followed by quenching with 125 mM glycine. Extract and sonicate chromatin to achieve fragments of approximately 200-500 bp, which can be verified by agarose gel electrophoresis. For immunoprecipitation, use 2-5 μg of SPCC13B11.04c antibody per sample and incubate overnight at 4°C with rotation . Include appropriate controls: an input sample (pre-immunoprecipitated chromatin), a negative control using non-specific IgG, and if available, a positive control targeting a known DNA-binding protein. After washing and reverse-crosslinking, purify DNA for analysis by qPCR or sequencing. For ChIP-seq analysis, follow established bioinformatic pipelines similar to those used in RNA polymerase II studies in S. pombe to identify genomic binding sites .

What approaches can be used to study potential interactions between SPCC13B11.04c and Loz1?

To investigate potential interactions between SPCC13B11.04c and the Loz1 transcription factor, researchers should employ multiple complementary approaches. Co-immunoprecipitation (Co-IP) experiments can be performed by immunoprecipitating either SPCC13B11.04c using the specific antibody or epitope-tagged Loz1, followed by Western blot analysis to detect the potential binding partner . For in vivo validation, proximity ligation assays or fluorescence resonance energy transfer (FRET) using fluorescently tagged proteins can provide evidence of physical interaction. Genetic interaction studies comparing single and double deletion mutants (SPCC13B11.04c∆, loz1∆, and SPCC13B11.04c∆ loz1∆) can reveal functional relationships between these genes . ChIP-seq experiments with both SPCC13B11.04c antibody and Loz1 antibody can identify potential co-occupancy at genomic loci, particularly regions containing the Loz1 Response Element (LRE) with the consensus sequence CGN(A/C)GATCNTY . RNA-seq analysis of these mutants can further elucidate their potential collaborative roles in transcriptional regulation.

How can researchers optimize immunofluorescence microscopy using SPCC13B11.04c antibody?

For successful immunofluorescence microscopy with SPCC13B11.04c antibody, sample preparation is critical. Fix S. pombe cells with 3.7% formaldehyde for 30 minutes at room temperature, followed by cell wall digestion using 1.2 M sorbitol containing 0.5 mg/ml zymolyase for 30-60 minutes. Permeabilize cells with 1% Triton X-100 for 2 minutes, then block with 1% BSA in PBS for 1 hour. Incubate with SPCC13B11.04c antibody at 1:100-1:500 dilution overnight at 4°C, followed by fluorophore-conjugated secondary antibody (1:500) for 1 hour at room temperature. Include DAPI staining (1 μg/ml) to visualize nuclei. For co-localization studies, combine with antibodies against known nuclear or cytoplasmic markers, ensuring secondary antibodies have non-overlapping emission spectra. Optimize signal-to-noise ratio by testing different antibody concentrations and detection settings. Confirm specificity using SPCC13B11.04c deletion strains as negative controls to rule out non-specific binding.

How can SPCC13B11.04c antibody be used to investigate zinc homeostasis mechanisms?

SPCC13B11.04c antibody can be instrumental in exploring zinc homeostasis mechanisms, particularly in relation to the Loz1 transcription factor pathway. Design experiments to examine SPCC13B11.04c protein levels under varying zinc concentrations using Western blot analysis with the antibody, comparing wild-type and loz1Δ strains to determine if SPCC13B11.04c expression is zinc-regulated in a Loz1-dependent manner . Employ ChIP-seq with SPCC13B11.04c antibody under high and low zinc conditions to identify potential zinc-responsive binding sites across the genome. Combine these approaches with RNA-seq analysis to correlate SPCC13B11.04c binding with transcriptional changes in zinc-responsive genes. For mechanistic studies, use the antibody in RNA immunoprecipitation (RIP) assays to investigate whether SPCC13B11.04c directly interacts with transcripts of zinc homeostasis genes. Additionally, co-immunoprecipitation experiments can reveal interactions with other proteins involved in zinc sensing or transport.

What techniques can be used to study SPCC13B11.04c in the context of RNA polymerase II regulation?

To investigate SPCC13B11.04c in RNA polymerase II regulation contexts, researchers should implement a multi-faceted approach beginning with ChIP-seq experiments using both SPCC13B11.04c antibody and RNA polymerase II antibodies to identify regions of co-occupancy across the genome . Sequential ChIP (Re-ChIP) can determine whether both proteins simultaneously occupy the same DNA regions. Precision nuclear run-on sequencing (PRO-seq) or native elongating transcript sequencing (NET-seq) can measure the impact of SPCC13B11.04c deletion on transcription elongation rates and pausing. Co-immunoprecipitation experiments using SPCC13B11.04c antibody followed by mass spectrometry can identify interactions with RNA polymerase II subunits or associated factors like ELL/EAF complex components mentioned in the literature . Functional studies comparing transcriptional profiles in wild-type versus SPCC13B11.04c deletion strains in the presence of transcription elongation inhibitors can further elucidate its role in polymerase regulation.

How might SPCC13B11.04c relate to other transcription elongation factors in S. pombe?

Research suggests potential functional relationships between SPCC13B11.04c and transcription elongation factors in S. pombe. To investigate these connections, researchers should perform co-immunoprecipitation experiments using SPCC13B11.04c antibody followed by Western blotting or mass spectrometry to identify interacting partners among known elongation factors such as Ell1, Eaf1, and Ebp1 . Genetic interaction studies comparing the phenotypes of single and double deletion mutants (e.g., SPCC13B11.04c∆, ell1∆, and SPCC13B11.04c∆ ell1∆) can reveal functional relationships between these genes. ChIP-seq experiments with SPCC13B11.04c antibody compared to ChIP profiles of Ell1, Eaf1, and Ebp1 can identify regions of genomic co-occupancy, particularly at genes with high RNA Pol II occupancy as mentioned in the literature . RNA-seq analysis of these deletion strains can further characterize their potentially overlapping roles in transcriptional regulation, especially at highly transcribed genes or in response to transcriptional stress.

What approaches can be used to investigate SPCC13B11.04c in chromatin regulation?

To explore SPCC13B11.04c's potential role in chromatin regulation, researchers should implement multiple complementary approaches. Begin with ChIP-seq using SPCC13B11.04c antibody combined with antibodies against histone modifications (H3K4me3, H3K36me3, H3K9me2/3) to identify correlations between SPCC13B11.04c localization and specific chromatin states . Investigate potential connections to heterochromatin formation by examining subtelomeric regions, where literature suggests potential regulatory roles . Perform genetic interaction studies between SPCC13B11.04c and genes involved in chromatin regulation, such as Brl1 or other components of chromatin remodeling complexes. Assay accessibility changes using ATAC-seq or MNase-seq in wild-type versus SPCC13B11.04c deletion strains to determine if chromatin structure is altered. Co-immunoprecipitation experiments using SPCC13B11.04c antibody can identify potential interactions with chromatin modifiers and remodelers. Additionally, microscopical approaches using immunofluorescence with SPCC13B11.04c antibody and markers of heterochromatin can visualize potential co-localization at specific nuclear regions.

What are common issues in Western blotting with SPCC13B11.04c antibody and how can they be resolved?

When troubleshooting Western blotting with SPCC13B11.04c antibody, several common issues may arise. For weak or absent signals, first verify protein transfer efficiency using reversible Ponceau S staining of the membrane. Optimize primary antibody concentration by testing dilutions between 1:500 and 1:2000, and consider extending primary antibody incubation to overnight at 4°C . High background can be addressed by increasing blocking time or concentration (5-10% BSA or milk), adding 0.1-0.5% Tween-20 to wash buffers, or implementing more stringent washing steps. Multiple bands may indicate protein degradation (add fresh protease inhibitors), post-translational modifications (confirm with phosphatase treatment), or non-specific binding (increase blocking and optimize antibody dilution). If the detected protein size differs from predicted, consider native modification states or processing of SPCC13B11.04c. For loading controls, use antibodies against conserved S. pombe proteins like α-tubulin or GAPDH to normalize expression data accurately.

How should researchers address potential cross-reactivity of SPCC13B11.04c antibody?

Addressing potential cross-reactivity of SPCC13B11.04c antibody requires systematic validation steps. Begin by comparing Western blot profiles from wild-type S. pombe extracts with those from SPCC13B11.04c deletion strains; any bands appearing in both samples indicate cross-reactivity with other proteins. Pre-absorption experiments can identify non-specific binding – incubate the antibody with recombinant SPCC13B11.04c protein before use; specific signals should disappear while cross-reactive bands persist. When performing immunofluorescence or immunohistochemistry, always include a SPCC13B11.04c deletion strain as a negative control. Consider epitope mapping to identify the specific sequences recognized by the antibody, then use BLAST searches to identify S. pombe proteins with similar sequences that might cross-react. For critical experiments where absolute specificity is required, consider generating a monoclonal antibody or using alternative approaches like epitope tagging of the endogenous SPCC13B11.04c gene to enable detection with highly specific commercial tag antibodies.

What controls are essential for ChIP experiments using SPCC13B11.04c antibody?

When performing ChIP experiments with SPCC13B11.04c antibody, implementing comprehensive controls is crucial for generating reliable and interpretable data. Always include an input sample (pre-immunoprecipitated chromatin) to normalize for differences in chromatin preparation and DNA abundance. A mock immunoprecipitation using non-specific IgG from the same species (rabbit) serves as a negative control to establish background signal levels . Include a positive control by immunoprecipitating a well-characterized chromatin-associated protein, such as histone H3. Technical validation should include qPCR of regions expected to be bound or unbound based on existing knowledge. For definitive specificity control, perform parallel ChIP experiments in SPCC13B11.04c deletion strains; any signal observed in these samples represents non-specific binding. When conducting ChIP-seq, include spike-in controls with chromatin from a different species to allow for quantitative comparisons between samples. Finally, biological replicates are essential to distinguish reproducible binding sites from technical artifacts.

How can inconsistent results between experiments be resolved?

Resolving inconsistent results between experiments using SPCC13B11.04c antibody requires systematic troubleshooting of both technical and biological variables. Begin by standardizing all experimental conditions, including cell growth phase, media composition, and environmental factors that might influence SPCC13B11.04c expression or localization. Implement strict quality control measures for the antibody, including regular validation of specificity and activity using positive and negative controls. Consider lot-to-lot variations in antibody production by recording lot numbers and testing new lots against previous ones before use in critical experiments. Standardize protein extraction methods, ensuring complete protease inhibition to prevent degradation. For quantitative applications, use internal controls and standard curves to normalize data between experiments. Biological variability can be addressed by increasing the number of biological replicates and applying appropriate statistical analyses. Document all experimental procedures in detail, including exact buffer compositions, incubation times, and equipment settings, to facilitate troubleshooting and reproduction of successful conditions.

How does SPCC13B11.04c research contribute to our understanding of S. pombe as a model organism?

Research on SPCC13B11.04c contributes significantly to our understanding of S. pombe as a eukaryotic model system by illuminating specialized aspects of transcriptional regulation in this organism. S. pombe serves as an excellent model due to its well-defined genetic system, facile techniques for genetic manipulation, and importance in unveiling central metabolic pathways . The characterization of SPCC13B11.04c function adds to the comprehensive functional genomic understanding of fission yeast, which encompasses genomic, transcriptomic, proteomic, and metabolomic levels of analysis . By integrating SPCC13B11.04c research into the broader context of S. pombe biology, researchers can better understand how individual proteins contribute to cellular networks and regulatory circuits. This protein may represent a species-specific adaptation in transcriptional regulation, potentially revealing evolutionary insights when compared to related mechanisms in other eukaryotes. Additionally, as a component potentially involved in zinc homeostasis through interaction with Loz1, SPCC13B11.04c research contributes to our understanding of metal homeostasis mechanisms in eukaryotic cells.

What are promising future research directions involving SPCC13B11.04c?

Future research involving SPCC13B11.04c should explore several promising directions to deepen our understanding of its cellular functions. Structural studies using X-ray crystallography or cryo-electron microscopy could elucidate the protein's domains and binding interfaces, particularly in complex with interaction partners like Loz1 or RNA polymerase II components. Developing tools for real-time visualization, such as fluorescently tagged SPCC13B11.04c, would allow monitoring of its dynamics during different cellular processes or in response to environmental stimuli like zinc availability . High-resolution techniques such as CUT&RUN or CUT&Tag could provide improved mapping of genomic binding sites compared to traditional ChIP-seq. Single-cell approaches examining SPCC13B11.04c expression and localization heterogeneity across cell populations could reveal previously unrecognized regulatory patterns. Integrating SPCC13B11.04c research with systems biology approaches would position its function within broader gene regulatory networks and metabolic processes . Finally, comparative studies with similar proteins in other yeast species could provide evolutionary insights into specialized transcriptional regulatory mechanisms.

How can researchers integrate SPCC13B11.04c studies with broader transcriptional regulation frameworks?

Integrating SPCC13B11.04c studies with broader transcriptional regulation frameworks requires multi-dimensional approaches that connect this specific protein to established regulatory mechanisms. Researchers should employ network analysis techniques that incorporate SPCC13B11.04c into known transcriptional regulatory circuits, particularly those involving zinc homeostasis and RNA polymerase II regulation . Multi-omics integration combining ChIP-seq, RNA-seq, and proteomics data can place SPCC13B11.04c function within global cellular response patterns. Comparative studies with model organisms like S. cerevisiae, where metabolic and transcriptional pathways are well-characterized, can highlight conserved and divergent aspects of SPCC13B11.04c function . Mathematical modeling approaches, such as those used in metabolic control analysis, can quantitatively assess SPCC13B11.04c's contribution to transcriptional regulation dynamics . Global genetic interaction screens comparing SPCC13B11.04c deletion with genome-wide mutant collections can unveil functional relationships with established transcriptional machinery components. Additionally, positioning SPCC13B11.04c within the architectural components of transcriptional regulation, such as chromatin remodeling complexes or mediator complexes, will provide context for its mechanistic contributions.

What techniques can advance our knowledge of SPCC13B11.04c's molecular function?

Advanced molecular techniques offer promising avenues to elucidate SPCC13B11.04c's precise functions. CRISPR-based approaches for endogenous tagging can enable visualization and purification of SPCC13B11.04c without overexpression artifacts. Proximity labeling methods such as BioID or APEX2 fused to SPCC13B11.04c can identify proteins in its immediate vicinity in living cells, potentially revealing transient or context-specific interactions. In vitro reconstitution assays using purified SPCC13B11.04c and suspected interaction partners can define direct physical interactions and their functional consequences. For nucleic acid interactions, CLIP-seq (Cross-Linking Immunoprecipitation followed by sequencing) using SPCC13B11.04c antibody can map RNA binding sites with nucleotide resolution . Domain mapping through systematic mutagenesis followed by functional assays can pinpoint critical regions for SPCC13B11.04c activity. Time-resolved studies examining SPCC13B11.04c localization and interaction dynamics throughout the cell cycle or in response to environmental stressors can reveal condition-specific functions. Combining these approaches with quantitative proteomics and phosphoproteomics will further illuminate how post-translational modifications regulate SPCC13B11.04c activity in different cellular contexts.